WPI 2233 (Tamoxifen 20 mg)

Pill imprint WPI 2233 has been identified as Tamoxifen citrate 20 mg.

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, metastatic; breast cancer, male; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WPI 2233 (Tamoxifen 20 mg)

Tamoxifen citrate 20 mg WPI 2233
Tamoxifen citrate 20 mg WPI 2233
Tamoxifen citrate
Imprint:
WPI
2233
Strength:
20 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals, Inc.
National Drug Code (NDC):
00591-2233
Inactive Ingredients:
croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
pregelatinized corn starch

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Learn about treatments for OA knee pain to help you stay active. Watch Video

Close
Hide
(web2)